1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Doximity, Inc.

Doximity, Inc.

DOCS
Doximity, Inc.US flagNew York Stock Exchange
20.04
USD
+0.02
- -
3.75BMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.57
0.77
1.16
2.1
2.17
2.5
3.05
3.45
3.45
Basic EPS, GAAP
0.05
0.2
0.28
0.95
0.58
0.78
1.19
1.05
1.05
Free Cash Flow per Basic Share
0.1
0.15
0.44
0.74
0.9
0.94
1.43
1.7
1.7
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.09
0.2
1.17
1.13
0.42
1
-0.27
-0.27
Tangible Book Value per Share
- -
- -
0.21
5.21
4.48
4.24
5.31
4.44
4.44
Basic Weighted Avg Shares
151
151
178
163
193
190
187
187
187
Sales/Revenue/Turnover
86
116
207
344
419
475
570
645
645
Operating Margin (%)
8.08
19.04
25.76
33.05
29.86
36.14
40.34
33.33
33.33
Depreciation Expense
1
1
4
5
10
10
11
14
14
Net Income, GAAP
8
30
50
155
113
148
223
196
196
Effective Tax Rate (%)
1.24
- -
13.08
- -
15.27
20.31
15.32
21.58
21.58
Profit Margin (%)
9.14
25.55
24.27
45.05
26.92
31.04
39.13
30.4
30.4
Working Capital
- -
67
107
793
836
766
932
789
789
LT Debt
- -
- -
- -
- -
14
12
10
8
8
Total Equity
- -
1
67
879
966
901
1,083
951
951
Return on Invested Capital (%)
- -
- -
132.61
- -
11.38
14.33
19.27
16.36
16.36
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
135.95
55.12
98.97
167.02
- -
724.22

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
9
9
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
188
185
183
Market Capitalization
13,738
8,319
4,357

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
1,092
993
944
Cash, Cash Equivalents & STI
878
735
749
Accounts Receivable, Net
129
157
145
Inventories
- -
- -
- -
Total Current Liabilities
140
150
155
Payables & Accruals
23
67
32
ST Debt
2
2
2
Deferred Revenue
100
66
106

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
245.52%
-12.17%
Free Cash Flow
- -
33.83%
19.03%
Net Income, GAAP
- -
50.21%
-12.16%
Sales/Revenue/Turnover
- -
26.9%
13.05%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
108
114
135
118
475
2025
127
137
169
138
570
2026
146
169
185
145
645

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.15
0.16
0.26
0.22
0.78
2025
0.22
0.24
0.4
0.33
1.19
2026
0.28
0.33
0.33
0.1
1.05

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

MCPAPIChat
CEO
Jeffrey A. Tangney
Full Time Employees
827
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
500, 3rd Street San Francisco CA United States of America 94107
IPO Date
Jun 24, 2021
CIK
0001516513
Website
doximity.com
Similar Companies
Sinohealth Technology Holdings Limited (2361.HK)
CompuGroup Medical SE & Co. KGaA (CMPVF)
Drug Free Solution, Inc. (DSOL)
CareMax, Inc. (CMAXW)
MSP Recovery, Inc. (MSPR)
EBM Technologies Incorporated (8409.TWO)
Business
I will refine the search specifically for latest major company changes for Doximity, Inc. to find accurate and recent updates.

Company News

MCPAPIChat

  • zacks.com

    Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?

  • prnewswire.com

    DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Doximity, Inc. – DOCS

  • gurufocus.com

    DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

  • prnewswire.com

    DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

  • prnewswire.com

    Did Five Below, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • businesswire.com

    DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

  • zacks.com

    OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • fool.com

    Doximity: A Strong Contender or Vulnerable to Disruption?

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • fool.com

    Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale?

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • businesswire.com

    Doximity to Present at the William Blair 46th Annual Growth Stock Conference

  • zacks.com

    OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds

  • proactiveinvestors.co.uk

    Dr Martens profits jump as turnaround gains grip

  • 247wallst.com

    Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss.